Enanta Stumbles In Trying To Show Better FXR Agonist Profile In NASH

 
• By Joseph Haas
Blood sample with requisition form for liver enzyme (AST, ALT) test - Image
Enanta's NASH drug lowered ALT levels, but the fuller picture is unclear

More from Clinical Trials

More from R&D